Kezar Life Sciences IncNASDAQ:KZRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.8044
- TODAY'S CHANGE (%)0.0312 (4.0352%)
- Bid / Lots0.8038/ 1
- Ask / Lots0.8044/ 99
- Open / Previous Close0.7650 / 0.7732
- Day Range
- 52 Week Range
- Volume3,038,028
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KZR |
|---|---|---|
| 09:32 ET | 25765 | 0.7732 |
| 09:34 ET | 106007 | 0.7998 |
| 09:36 ET | 42404 | 0.8098 |
| 09:38 ET | 23518 | 0.80465 |
| 09:39 ET | 11440 | 0.8046 |
| 09:41 ET | 51337 | 0.79 |
| 09:43 ET | 21703 | 0.79 |
| 09:45 ET | 2700 | 0.785 |
| 09:48 ET | 35900 | 0.8021 |
| 09:50 ET | 19854 | 0.7875 |
| 09:52 ET | 1600 | 0.7975 |
| 09:54 ET | 9693 | 0.79749 |
| 09:56 ET | 24390 | 0.8 |
| 09:57 ET | 18310 | 0.799 |
| 09:59 ET | 30281 | 0.7991 |
| 10:01 ET | 108232 | 0.772 |
| 10:03 ET | 25100 | 0.78 |
| 10:06 ET | 78840 | 0.7985 |
| 10:08 ET | 24650 | 0.8 |
| 10:10 ET | 5620 | 0.7963 |
| 10:12 ET | 9079 | 0.7999 |
| 10:14 ET | 30900 | 0.79835 |
| 10:15 ET | 52285 | 0.7956 |
| 10:17 ET | 6711 | 0.793 |
| 10:19 ET | 5700 | 0.791 |
| 10:21 ET | 12011 | 0.7957 |
| 10:24 ET | 69915 | 0.8092 |
| 10:26 ET | 36300 | 0.805 |
| 10:28 ET | 53826 | 0.8071 |
| 10:30 ET | 7400 | 0.809 |
| 10:32 ET | 29479 | 0.81 |
| 10:33 ET | 51188 | 0.80695 |
| 10:35 ET | 27710 | 0.8078 |
| 10:37 ET | 11530 | 0.8039 |
| 10:39 ET | 22651 | 0.800136 |
| 10:42 ET | 9809 | 0.8039 |
| 10:44 ET | 9000 | 0.8024 |
| 10:46 ET | 2398 | 0.8039 |
| 10:48 ET | 4425 | 0.8008 |
| 10:50 ET | 8642 | 0.8039 |
| 10:51 ET | 28382 | 0.7999 |
| 10:53 ET | 1200 | 0.7944 |
| 10:55 ET | 11975 | 0.798 |
| 10:57 ET | 4900 | 0.7985 |
| 11:00 ET | 4650 | 0.8 |
| 11:02 ET | 10497 | 0.799 |
| 11:04 ET | 9249 | 0.799 |
| 11:06 ET | 23400 | 0.799 |
| 11:08 ET | 9803 | 0.7962 |
| 11:09 ET | 6100 | 0.7967 |
| 11:11 ET | 59982 | 0.7969 |
| 11:13 ET | 4700 | 0.7999 |
| 11:15 ET | 8050 | 0.8 |
| 11:18 ET | 19850 | 0.801 |
| 11:20 ET | 8233 | 0.8016 |
| 11:22 ET | 10100 | 0.8015 |
| 11:24 ET | 9000 | 0.8039 |
| 11:26 ET | 17780 | 0.805 |
| 11:27 ET | 67291 | 0.8071 |
| 11:29 ET | 2500 | 0.8043 |
| 11:31 ET | 35223 | 0.8151 |
| 11:33 ET | 28350 | 0.81705 |
| 11:36 ET | 11625 | 0.8191 |
| 11:38 ET | 9267 | 0.8146 |
| 11:40 ET | 47013 | 0.8001 |
| 11:42 ET | 7095 | 0.8098 |
| 11:44 ET | 8153 | 0.805 |
| 11:45 ET | 19800 | 0.8097 |
| 11:47 ET | 18345 | 0.8097 |
| 11:49 ET | 80723 | 0.8071 |
| 11:51 ET | 8349 | 0.8103 |
| 11:54 ET | 8290 | 0.815 |
| 11:56 ET | 9720 | 0.8179 |
| 11:58 ET | 50599 | 0.8014 |
| 12:00 ET | 4814 | 0.8014 |
| 12:02 ET | 5398 | 0.806 |
| 12:03 ET | 11400 | 0.8 |
| 12:05 ET | 7614 | 0.79 |
| 12:07 ET | 7001 | 0.793 |
| 12:09 ET | 12900 | 0.788 |
| 12:12 ET | 2100 | 0.798 |
| 12:14 ET | 6400 | 0.7946 |
| 12:16 ET | 7100 | 0.799 |
| 12:18 ET | 800 | 0.7947 |
| 12:20 ET | 9584 | 0.8049 |
| 12:21 ET | 1300 | 0.8047 |
| 12:23 ET | 6700 | 0.805 |
| 12:25 ET | 16648 | 0.8054 |
| 12:27 ET | 5200 | 0.8054 |
| 12:30 ET | 5103 | 0.8053 |
| 12:32 ET | 5740 | 0.8058 |
| 12:34 ET | 7422 | 0.8058 |
| 12:36 ET | 1564 | 0.8058 |
| 12:38 ET | 6020 | 0.805 |
| 12:39 ET | 6174 | 0.8027 |
| 12:41 ET | 16944 | 0.8043 |
| 12:43 ET | 5794 | 0.8037 |
| 12:45 ET | 19670 | 0.7958 |
| 12:48 ET | 6152 | 0.805 |
| 12:50 ET | 3100 | 0.8042 |
| 12:52 ET | 4400 | 0.8096 |
| 12:54 ET | 5725 | 0.805 |
| 12:56 ET | 6322 | 0.8021 |
| 12:57 ET | 1000 | 0.802 |
| 12:59 ET | 5881 | 0.805 |
| 01:01 ET | 4993 | 0.8055 |
| 01:03 ET | 31141 | 0.805 |
| 01:06 ET | 4803 | 0.8046 |
| 01:08 ET | 5498 | 0.7995 |
| 01:10 ET | 6001 | 0.7995 |
| 01:12 ET | 6100 | 0.799 |
| 01:14 ET | 3679 | 0.7945 |
| 01:15 ET | 16855 | 0.786 |
| 01:17 ET | 46254 | 0.7699 |
| 01:19 ET | 5321 | 0.774101 |
| 01:21 ET | 7970 | 0.78 |
| 01:24 ET | 2200 | 0.78 |
| 01:26 ET | 7023 | 0.7798 |
| 01:28 ET | 900 | 0.7798 |
| 01:30 ET | 4400 | 0.7798 |
| 01:32 ET | 5200 | 0.7799 |
| 01:33 ET | 6498 | 0.7767 |
| 01:35 ET | 44642 | 0.786 |
| 01:37 ET | 6500 | 0.786 |
| 01:39 ET | 3500 | 0.7911 |
| 01:42 ET | 9100 | 0.7896 |
| 01:44 ET | 6682 | 0.7896 |
| 01:46 ET | 3300 | 0.7878 |
| 01:48 ET | 5868 | 0.782 |
| 01:50 ET | 5500 | 0.777 |
| 01:51 ET | 2584 | 0.7878 |
| 01:53 ET | 5200 | 0.7878 |
| 01:55 ET | 3700 | 0.7837 |
| 01:57 ET | 2800 | 0.7973 |
| 02:00 ET | 6100 | 0.797 |
| 02:02 ET | 4000 | 0.7966 |
| 02:04 ET | 25606 | 0.7845 |
| 02:06 ET | 21798 | 0.7898 |
| 02:08 ET | 9045 | 0.7947 |
| 02:09 ET | 6384 | 0.7947 |
| 02:11 ET | 14269 | 0.7978 |
| 02:13 ET | 12618 | 0.7984 |
| 02:15 ET | 9427 | 0.7964 |
| 02:18 ET | 5186 | 0.7949 |
| 02:20 ET | 8653 | 0.795 |
| 02:22 ET | 4300 | 0.7936 |
| 02:24 ET | 9509 | 0.795 |
| 02:26 ET | 6300 | 0.7939 |
| 02:27 ET | 6200 | 0.795 |
| 02:29 ET | 8329 | 0.7949 |
| 02:31 ET | 8700 | 0.795 |
| 02:33 ET | 42519 | 0.795 |
| 02:36 ET | 11627 | 0.795 |
| 02:38 ET | 15295 | 0.7933 |
| 02:40 ET | 9659 | 0.795 |
| 02:42 ET | 9738 | 0.7941 |
| 02:44 ET | 13437 | 0.8 |
| 02:45 ET | 13792 | 0.8 |
| 02:47 ET | 6200 | 0.8 |
| 02:49 ET | 18456 | 0.8 |
| 02:51 ET | 4300 | 0.8005 |
| 02:54 ET | 11961 | 0.8005 |
| 02:56 ET | 7250 | 0.8 |
| 02:58 ET | 14420 | 0.8003 |
| 03:00 ET | 17919 | 0.7987 |
| 03:02 ET | 9099 | 0.8 |
| 03:03 ET | 10721 | 0.8 |
| 03:05 ET | 14281 | 0.8 |
| 03:07 ET | 12711 | 0.799 |
| 03:09 ET | 9900 | 0.7995 |
| 03:12 ET | 14806 | 0.7995 |
| 03:14 ET | 4616 | 0.7995 |
| 03:16 ET | 20190 | 0.8 |
| 03:18 ET | 15605 | 0.7995 |
| 03:20 ET | 16500 | 0.8 |
| 03:21 ET | 7232 | 0.8001 |
| 03:23 ET | 10900 | 0.8001 |
| 03:25 ET | 11407 | 0.7969 |
| 03:27 ET | 10450 | 0.8 |
| 03:30 ET | 7288 | 0.8 |
| 03:32 ET | 9643 | 0.8 |
| 03:34 ET | 10963 | 0.8049 |
| 03:36 ET | 26541 | 0.8029 |
| 03:38 ET | 19687 | 0.79075 |
| 03:39 ET | 8412 | 0.8013 |
| 03:41 ET | 10180 | 0.8026 |
| 03:43 ET | 26685 | 0.8038 |
| 03:45 ET | 23386 | 0.805 |
| 03:48 ET | 34400 | 0.8044 |
Yesterday
DJ Kezar Life Sciences Halts Trial of Lupus-Nephritis Treatment After Deaths, from 2:39PM ET on Monday Sep 30, 2024 by Dow Jones
2:39PM ET on Monday Sep 30, 2024 by Dow JonesKezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients, from 8:30AM ET on Monday Sep 30, 2024 by Dow Jones
8:30AM ET on Monday Sep 30, 2024 by Dow Jones
Sep 4, 2024
Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference, from 4:01PM ET on Wednesday Sep 04, 2024 by Dow Jones
4:01PM ET on Wednesday Sep 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kezar Life Sciences Inc | 56.4M | -0.6x | --- |
Kronos Bio Inc | 60.3M | -0.6x | --- |
LAVA Therapeutics NV | 43.6M | -1.9x | --- |
BioLine RX Ltd | 52.6M | -0.7x | --- |
Syros Pharmaceuticals Inc | 57.6M | -0.5x | --- |
Cue Biopharma Inc | 45.6M | -0.7x | --- |
Company Information
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. The Company's lead product candidate, zetomipzomib, is a first-in-class selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib/IIa clinical trial in patients with systemic lupus erythematosus (SLE), with or without lupus nephritis (LN). Its oncology product candidate, KZR-261, is a small molecule agent, targeting the Sec61 translocon and protein secretion pathway, being studied in an open-label Phase I clinical trial designed to evaluate safety and tolerability, pharmacokinetics and pharmacodynamics, as well to explore preliminary anti-tumor activity. This study is being conducted in two parts: dose escalation in patients with locally advanced or metastatic solid malignancies, and dose expansion in patients with selected tumor types.
Contact Information
- Headquarters
- 4000 Shoreline Ct Ste 300SOUTH SAN FRANCISCO, CA, United States 94080-2005
- Phone
- 650-822-5600
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Graham Cooper
- Chief Executive Officer, Director
- Christopher Kirk
- Chief Financial Officer, Secretary
- Marc Belsky
- Chief Business Officer
- Nick Mordwinkin
- Chief Legal Officer
- Mark Schiller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $56.4M |
|---|---|
Revenue (TTM) | $7.0M |
Shares Outstanding | 73.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.21 |
EPS | $-1.35 |
Book Value | $2.58 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 8.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,531.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
